Case report demonstrates improved diagnostic accuracy for CNS large B-cell lymphoma using noninvasive CSF analyses.
Rationale: Primary central nervous system (CNS) large B-cell lymphoma (PCNS-LBCL) is a rare and aggressive brain malignancy that is challenging to diagnose early. Conventional imaging methods, such as magnetic resonance imaging and PET-CT, may not provide conclusive results in the early stages. This case highlights the diagnostic utility of cerebrospinal fluid (CSF) IgG index, 24-hour IgG synthesis rate, and immunophenotyping, offering a reliable noninvasive approach to improve early diagnosis when imaging results are inconclusive. Patient concerns: A 57-year-old male presented with progressively worsening headache, altered consciousness, and cognitive impairment, which developed gradually over several weeks. These symptoms prompted further diagnostic evaluation to identify the underlying cause. Diagnoses: Magnetic resonance imaging revealed nonspecific abnormalities, while PET-CT showed increased metabolic activity in regions suspicious for malignancy. CSF analysis demonstrated an elevated IgG index and 24-hour IgG synthesis rate, indicating CNS immune activation. Flow cytometry revealed abnormal B-lymphocytes, confirming the diagnosis of PCNS-LBCL. Interventions: The patient received a combined treatment regimen of R-CHOP chemotherapy and intrathecal methotrexate (MTX), chosen due to its ability to penetrate the blood–brain barrier and directly target CNS lesions. This combined approach is essential for treating PCNS-LBCL and preventing further neurological damage. Outcomes: Following treatment, the patient showed significant clinical improvement, with normalization of CSF parameters and recovery of neurological function, including improved cognitive abilities and motor skills. At the 1-year follow-up, imaging studies showed no relapse, and flow cytometry confirmed the absence of abnormal B-lymphocytes. Lessons: This case demonstrates the potential of integrating CSF IgG index, 24-hour IgG synthesis rate, and immunophenotyping as reliable, noninvasive diagnostic tools for the early detection of PCNS-LBCL, especially when imaging findings are inconclusive. The approach may offer valuable insights for improving diagnostic accuracy in clinical practice.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: